AI assistant
INSMED Inc — Director's Dealing 2025
Jun 4, 2025
30150_dirs_2025-06-04_f01e24e6-972f-46b8-9992-5fa4c8dd40ad.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-06-03
Reporting Person: MCGIRR DAVID W J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-03 | Common Stock | S | 3250 | $71.30 | Disposed | 100723 | Direct |
| 2025-06-04 | Common Stock | S | 3000 | $73.27 | Disposed | 97723 | Direct |
Footnotes
F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: This is the weighted average sales price representing 3,250 shares sold at prices ranging from $71.09 to $71.54 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: This is the weighted average sales price representing 3,000 shares sold at prices ranging from $73.13 to $73.41 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.